| Website | barosense.com |
| Category | BioTech |
| Phone | (650) 362-6000 |
| desiree@BaroSense... | |
| Employees | |
| Founded | 2001 |
| Description | med devices to treat obesity |
| TOTAL | $27M |
| FUNDING TOTAL | $27M |
| Series D, 8/09 Delphi Ventures Frazier Healthcare Ventures RWI Ventures Synergy Life Science Partner Wharton Ventures Pappas Ventures INVESCO Private Capital | $27M |
| Series B, 11/09 iNovia Capital |
BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.
